Convalescent Plasma as a Possible Treatment for COVID-19

Recruiting

Phase 2

Convalescent PlasmaConvalescent Plasma as a Possible Treatment for COVID-19

Sponsor:

University of Illinois at Chicago

Code:

NCT04442191

Conditions

COVID-19

Eligibility Criteria

Sex: All

Age: 40+

Healthy Volunteers: Not accepted

Interventions

Convalescent plasma

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-01. This information was provided to ClinicalTrials.gov by University of Illinois at Chicago on 2020-06-22.